SE8801708L - Ny anvaendning av dopamnreceptoragonister - Google Patents
Ny anvaendning av dopamnreceptoragonisterInfo
- Publication number
- SE8801708L SE8801708L SE8801708A SE8801708A SE8801708L SE 8801708 L SE8801708 L SE 8801708L SE 8801708 A SE8801708 A SE 8801708A SE 8801708 A SE8801708 A SE 8801708A SE 8801708 L SE8801708 L SE 8801708L
- Authority
- SE
- Sweden
- Prior art keywords
- receptor agonists
- dopamn
- new use
- lergotrile
- lisuride
- Prior art date
Links
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 206010057852 Nicotine dependence Diseases 0.000 abstract 1
- BKRGVLQUQGGVSM-KBXCAEBGSA-N Revanil Chemical compound C1=CC(C=2[C@H](N(C)C[C@H](C=2)NC(=O)N(CC)CC)C2)=C3C2=CNC3=C1 BKRGVLQUQGGVSM-KBXCAEBGSA-N 0.000 abstract 1
- 208000025569 Tobacco Use disease Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960002802 bromocriptine Drugs 0.000 abstract 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 abstract 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- JKAHWGPTNVUTNB-IXPVHAAZSA-N lergotrile Chemical compound C1=CC([C@H]2C[C@@H](CC#N)CN([C@@H]2C2)C)=C3C2=C(Cl)NC3=C1 JKAHWGPTNVUTNB-IXPVHAAZSA-N 0.000 abstract 1
- 229950007886 lergotrile Drugs 0.000 abstract 1
- 229960003587 lisuride Drugs 0.000 abstract 1
- 229960004851 pergolide Drugs 0.000 abstract 1
- YEHCICAEULNIGD-MZMPZRCHSA-N pergolide Chemical compound C1=CC([C@H]2C[C@@H](CSC)CN([C@@H]2C2)CCC)=C3C2=CNC3=C1 YEHCICAEULNIGD-MZMPZRCHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4775387A | 1987-05-07 | 1987-05-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8801708D0 SE8801708D0 (sv) | 1988-05-05 |
| SE8801708L true SE8801708L (sv) | 1988-11-08 |
Family
ID=21950776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8801708A SE8801708L (sv) | 1987-05-07 | 1988-05-05 | Ny anvaendning av dopamnreceptoragonister |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS63287723A (enExample) |
| KR (1) | KR880013556A (enExample) |
| AU (1) | AU622614B2 (enExample) |
| CH (1) | CH675834A5 (enExample) |
| DE (1) | DE3814521A1 (enExample) |
| DK (1) | DK245388A (enExample) |
| FR (1) | FR2614789B1 (enExample) |
| GB (1) | GB2204240B (enExample) |
| IT (1) | IT1219564B (enExample) |
| NL (1) | NL8801171A (enExample) |
| PH (1) | PH25495A (enExample) |
| SE (1) | SE8801708L (enExample) |
| ZA (1) | ZA883237B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797405A (en) * | 1987-10-26 | 1989-01-10 | Eli Lilly And Company | Stabilized pergolide compositions |
| DE19626621A1 (de) * | 1996-07-02 | 1998-01-08 | Hexal Ag | Pflaster zur transdermalen Anwendung von Pergolid |
| US6623752B1 (en) | 1996-07-02 | 2003-09-23 | Hexal Ag | Patch for transdermal application for pergolid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR861128B (en) * | 1985-05-06 | 1986-08-26 | Sandoz Ag | New use of dopamine agonists |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
-
1988
- 1988-04-29 DE DE3814521A patent/DE3814521A1/de not_active Withdrawn
- 1988-05-02 FR FR888805957A patent/FR2614789B1/fr not_active Expired - Lifetime
- 1988-05-03 IT IT47906/88A patent/IT1219564B/it active
- 1988-05-04 CH CH1664/88A patent/CH675834A5/de not_active IP Right Cessation
- 1988-05-04 NL NL8801171A patent/NL8801171A/nl not_active Application Discontinuation
- 1988-05-04 GB GB8810509A patent/GB2204240B/en not_active Expired - Lifetime
- 1988-05-05 DK DK245388A patent/DK245388A/da not_active Application Discontinuation
- 1988-05-05 AU AU15605/88A patent/AU622614B2/en not_active Expired - Fee Related
- 1988-05-05 ZA ZA883237A patent/ZA883237B/xx unknown
- 1988-05-05 SE SE8801708A patent/SE8801708L/ not_active Application Discontinuation
- 1988-05-06 JP JP63109280A patent/JPS63287723A/ja active Pending
- 1988-05-06 PH PH36895A patent/PH25495A/en unknown
- 1988-05-06 KR KR1019880005250A patent/KR880013556A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2614789B1 (fr) | 1991-10-18 |
| SE8801708D0 (sv) | 1988-05-05 |
| ZA883237B (en) | 1990-01-31 |
| NL8801171A (nl) | 1988-12-01 |
| KR880013556A (ko) | 1988-12-21 |
| DK245388D0 (da) | 1988-05-05 |
| DK245388A (da) | 1988-11-08 |
| GB8810509D0 (en) | 1988-06-08 |
| IT1219564B (it) | 1990-05-18 |
| AU1560588A (en) | 1988-11-10 |
| GB2204240A (en) | 1988-11-09 |
| CH675834A5 (enExample) | 1990-11-15 |
| GB2204240B (en) | 1991-04-24 |
| FR2614789A1 (fr) | 1988-11-10 |
| IT8847906A0 (it) | 1988-05-03 |
| PH25495A (en) | 1991-07-24 |
| DE3814521A1 (de) | 1988-11-17 |
| AU622614B2 (en) | 1992-04-16 |
| JPS63287723A (ja) | 1988-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO910187D0 (no) | Fremgangsmaate for fremstilling av indolsubstituerte, heteroaromatiske femringforbindelser. | |
| ATE293989T1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
| IT1219906B (it) | Impieghi in terapeutica degli agonisti dei recettori dopaminergici | |
| NO165344C (no) | Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater. | |
| DE69414398D1 (de) | Heterocyclische neurokinin-antagonisten | |
| PL268927A1 (en) | Method of obtaining novel derivatives of benzimidazole | |
| NO20004419D0 (no) | Ny anvendelse | |
| SE8400445D0 (sv) | Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use | |
| SI1202727T1 (enExample) | ||
| Midham et al. | Radioimmunoassay for fluphenazine in human plasma. | |
| SE8801708L (sv) | Ny anvaendning av dopamnreceptoragonister | |
| SE433353B (sv) | Analogiforfarande for framstellning av pyrido/1,2-a/pyrimidiner med antiflogistisk och koagulationshemmande verkan | |
| NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
| IT1203782B (it) | Impiego in terapeutica degli agonisti dopaminergici | |
| IT8948215A0 (it) | Impiego in terapeutica dei derivati della benzo (g) chinolina per il trattamento della dipendenza della nicotina | |
| SE8600496L (sv) | Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider | |
| ES2098263T3 (es) | 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. | |
| ES469908A1 (es) | Procedimiento de utilizacion de salinomicina. | |
| EP0417637A3 (en) | Use of dopamine autoreceptor agonists in the treatment of drug dependency | |
| DE58909244D1 (de) | Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht. | |
| NO172114C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte bifenyler | |
| DK480979A (da) | Fremgangsmaade til fremstilling af 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophen-4,9-iminer | |
| BG50187A1 (en) | Solid medicinal form on the basis of ergoalkaloid derivatides | |
| NO164544C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive hydrazonderivater med morfinan-skjelett. | |
| ES8403898A1 (es) | Procedimiento para preparar derivados de ergolina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8801708-2 Effective date: 19911125 Format of ref document f/p: F |